VaxCorps Announces Massive Expansion of Vaccine Research Network
Share Article
VaxCorps, a U.S. and Canada based integrated research organization specializing in the conduct of vaccine trials, today announced the expansion to the network of three new partners Coastal Carolina Research Center, Elligo Health Research, and Javara Research adding additional vaccine capabilities and capacity required to support its rapid business growth. AUSTIN, Texas (PRWEB) May 04, 2021 VaxCorps’ expansion includes more vaccine companies than any other network, including the global integration of Benchmark Research, CenExcel (Research Centers of America) and LMC Manna Research. These new partnerships more than double the number of sites within the current VaxCorps network, adding 12 new states and most of Canada. With this vast expansion, VaxCorps continues to grow its access to diverse patient populations.
CRAACO tackles ways to strengthen care, patient connection
outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.
Elligo hits 100-million patient mark with network Thanks to collaborations with Cerner, amassing of proprietary data and other achievements, the trial solutions firm has hit a significant access milestone.
Elligo Health Research has announced it now has the ability to connect clinical trial teams with access to more than 100m patients. According to the company, the milestone has been made possible via the company’s proprietary data, as well as collaborations with firms such as Cerner, which offers the Learning Health Network of nationwide health systems committed to sharing data in the support of advancing clinical research.
At a virtual press event on Monday, February 1, Elligo Health Research CEO John Potthoff told Outsourcing-Pharma that partnerships with Cerner and other companies helps to broaden the array of solutions and access available to clinical trial professionals.
The two firms will work together to broaden the technology, tools, and resources available to hospitals and practices in less-accessible communities.
Cerner, a global health care technology firm, has announced investment in integrated research organization Elligo Health Research. Cerner will enter into a commercial agreement to expand data and tools available in its Cerner Learning Health Network to increase trial resources available to community and rural hospitals and practices; Cerner representatives also will join Elligo’s board.
John Potthoff, CEO of Elligo, told Outsourcing-Pharma that the alliance made sense, considering the similar aims of the two firms.
“
Given the overlap of our missions, we have known each other for a while now: Cerner for its access to practices and patients; Elligo for its ability to execute trials in healthcare,” he told us. “